Revumenib Citrate

SKU: orb2814857

Description

Revumenib (SNDX-5613) is a potent and selective small molecule inhibitor of the Menin-MLL interaction, used for researching MLL-rearranged leukemias such as ALL and AML. It has demonstrated activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a targeted therapeutic agent.

Key Properties

• CAS Number: 2761046-45-9
• MW: 840.96
• Formula: C₃₈H₅₇FN₆O₁₂S
• SMILES: C(CC(O)=O)(CC(O)=O)(C(O)=O)O.C(N1CCC2(CN(C2)C=3C(OC4=C(C(N(C(C)C)CC)=O)C=C(F)C=C4)=CN=CN3)CC1)[C@@H]5CC[C@@H](NS(CC)(=O)=O)CC5.O

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

169490859